Search

Your search keyword '"Moriarty, Andrew"' showing total 166 results

Search Constraints

Start Over You searched for: Author "Moriarty, Andrew" Remove constraint Author: "Moriarty, Andrew"
166 results on '"Moriarty, Andrew"'

Search Results

1. Factors Associated With Coronary Angiography Performed Within 6 Months of Randomization to the Conservative Strategy in the ISCHEMIA Trial

2. Patterns of oral anticoagulant use and outcomes in Asian patients with atrial fibrillation: a post-hoc analysis from the GLORIA-AF Registry

3. Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol

4. NT-proBNP Response to Sacubitril/Valsartan in Hospitalized Heart Failure Patients With Reduced Ejection Fraction: TRANSITION Study

6. Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

7. Sex Differences in Revascularization, Treatment Goals, and Outcomes of Patients With Chronic Coronary Disease: Insights From the ISCHEMIA Trial

8. The development and validation of a prognostic model to PREDICT Relapse of depression in adult patients in primary care: protocol for the PREDICTR study

9. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

12. Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial

13. Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial

16. Treating subclinical hypothyroidism in individuals with or without mental health problems – a Delphi based expert consensus study in two countries

17. Occurrence of death and stroke in patients in 47 countries 1 year after presenting with atrial fibrillation: a cohort study

19. Survival After Invasive or Conservative Management of Stable Coronary Disease

20. Sleep health among people with severe mental ill health during the COVID-19 pandemic: Results from a linked UK population cohort study

21. Identifying the top research priorities in medically not yet explained symptoms (MNYES): a James Lind Alliance priority setting partnership

22. Correction to: Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry (Clinical Research in Cardiology, (2022), 111, 5, (560-573), 10.1007/s00392-022-01996-2)

23. Identifying the top research priorities in medically not yet explained symptoms (MNYES): A James Lind Alliance priority setting partnership

27. Effect of a brief motivational interview and text message intervention targeting tobacco smoking, alcohol use, and medication adherence to improve tuberculosis treatment outcomes in adult patients with tuberculosis : A multicentre, randomised controlled trial of the ProLife programme in South Africa

29. Predicting relapse or recurrence of depression: systematic review of prognostic models

31. Interventions for preventing relapse or recurrence of major depressive disorder in adults in a primary care setting: a network meta-analysis

35. Privileged Structure: Novel Indane Scaffolds as Potential Anticancer and Anti-Inflammatory Agents

37. NT-proBNP Response to Sacubitril/Valsartan in Hospitalized Heart Failure Patients With Reduced Ejection Fraction

43. Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes

44. Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome ODYSSEY OUTCOMES Trial

45. Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events The ODYSSEY OUTCOMES Trial

46. Initiation of sacubitril/valsartan in haemodynamically stabilised heart failure patients in hospital or early after discharge: primary results of the randomised TRANSITION study

47. Additional file 2 of ImPROving TB outcomes by modifying LIFE-style behaviours through a brief motivational intervention followed by short text messages (ProLife): study protocol for a randomised controlled trial

48. Additional file 1 of ImPROving TB outcomes by modifying LIFE-style behaviours through a brief motivational intervention followed by short text messages (ProLife): study protocol for a randomised controlled trial

49. Additional file 4 of ImPROving TB outcomes by modifying LIFE-style behaviours through a brief motivational intervention followed by short text messages (ProLife): study protocol for a randomised controlled trial

50. Effects of alirocumab on types of myocardial infarction : insights from the ODYSSEY OUTCOMES trial

Catalog

Books, media, physical & digital resources